Next Generation Diabetes Therapy and Drug Delivery Market Insights Video
According to Cognitive Market Research, the global Next Generation Diabetes Therapy and Drug Delivery market size will be USD 10215.6 million in 2024. It will expand at a compound annual growth rate (CAGR) of 15.20% from 2024 to 2031.
North America held the major market share for more than 40% of the global revenue with a market size of USD 4086.24 million in 2024 and will grow at a compound annual growth rate (CAGR) of 13.4% from 2024 to 2031.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 3064.68 million in 2024 and will grow at a compound annual growth rate (CAGR) of 13.7% from 2024 to 2031.
Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 2349.59 million in 2024 and will grow at a compound annual growth rate (CAGR) of 17.2% from 2024 to 2031.
Latin America had a market share of more than 5% of the global revenue with a market size of USD 510.78 million in 2024 and will grow at a compound annual growth rate (CAGR) of 14.6% from 2024 to 2031.
Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 204.31 million in 2024 and will grow at a compound annual growth rate (CAGR) of 14.9% from 2024 to 2031.
The CGM systems held the highest Next Generation Diabetes Therapy and Drug Delivery market revenue share in 2024.
